Onward Medical Appoints Ali Kiboro as Chief Financial Officer

Experienced Financial Leadership

Ali Kiboro brings over 25 years of experience in financial leadership, particularly in the medical technology, diagnostics, and general industry sectors, according to the press release. He previously held the position of Chief Financial Officer at AliveDx, formerly Quotient Limited, a NASDAQ-listed company, where he oversaw financial strategy, capital market activities, and operational transformation. Prior to that, he served in various financial leadership roles at Quest Diagnostics and General Motors, the company states.

Strategic Addition to Onward Medical

Dave Marver, CEO of Onward Medical, stated that Ali Kiboro's experience in growing and developing life sciences companies is a valuable asset for the company at this stage of its development. For his part, Ali Kiboro expressed excitement about joining Onward Medical during a dynamic period, citing the company's mission, technology platforms, and advances in innovation and commercialization. He holds an MBA in Finance from the Wharton School of the University of Pennsylvania and a Bachelor's degree in Finance from Duquesne University, the press release notes.

Innovative Medical Technologies

Onward Medical develops therapies aimed at restoring movement and autonomy in individuals with spinal cord injuries and other movement disorders. The company has developed its proprietary ARC Therapy technology, which has received ten breakthrough device designations from the FDA, according to the press release. Its ARC EX system is authorized for marketing in the United States and Europe. The company is also developing an experimental implantable system, ARC-IM, designed to address several unmet needs, including blood pressure instability following spinal cord injury. Based in the Netherlands, Onward Medical is listed on Euronext Paris, Brussels, and Amsterdam under the ticker ONWD, and its American ADRs are traded on OTCQX under the ticker ONWRY.